Peptide Graded

Brilacidin

Is Brilacidin legal in the US?

Not yet; it is still in trials.

CAnimal and cell studiesIn clinical trialsas of 2026-10-26

Brilacidin is an investigational compound from Innovation Pharmaceuticals and is not approved by the FDA for any use. It has been tested in phase 2 trials for skin infections, oral mucositis, ulcerative proctitis and COVID-19, none of which has led to a marketing application. 12

No. It has been through phase 2 trials in several conditions. But no one has filed for approval, and no trial results have been published in a peer-reviewed journal. 12

Read the full Brilacidin page

More on Brilacidin

Citations

  1. Bakovic 2021, Viruses: brilacidin demonstrates inhibition of SARS-CoV-2 in cell culture doi.org
  2. Hu 2022, J Med Virol: brilacidin shows broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 doi.org
  3. Innovation Pharmaceuticals 2021 press release: topline results from the phase 2 trial of brilacidin for COVID-19 markets.financialcontent.com

Reference information only, not medical advice. Drawn from the Brilacidin article, fact-checked against the cited sources. No dosing anywhere on this site.